Similar articles

• Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine.

  Kasel JA, Hume EB, Fulk RV, Togo Y, Huber M, Hornick RB. Kasel JA, et al. J Immunol. 1969 Mar;102(3):555-62. J Immunol. 1969. PMID: 5773312 No abstract available.
• Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.

  Fedson DS, Fulk RV, Huber MA, Reisberg MA, Kasel JA. Fedson DS, et al. J Immunol. 1971 Sep;107(3):730-7. J Immunol. 1971. PMID: 4999093 No abstract available.
• Antibody response in respiratory secretions of volunteers given live and dead influenza virus.

  Mann JJ, Waldman RH, Togo Y, Heiner GG, Dawkins AT, Kasel JA. Mann JJ, et al. J Immunol. 1968 Apr;100(4):726-35. J Immunol. 1968. PMID: 5645216 No abstract available.
• [Vaccine prophylaxis of influenza in persons with chronic pathology].

  Rudenko LG, Zykov MP. Rudenko LG, et al. Zh Mikrobiol Epidemiol Immunobiol. 1982 Oct;(10):10-4. Zh Mikrobiol Epidemiol Immunobiol. 1982. PMID: 6758427 Review. Russian. No abstract available.
• [Bronchopulmonary defense mechanisms and their implications in pathology].

  Eskenasy A. Eskenasy A. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1979 Jul-Sep;28(3):129-35. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1979. PMID: 229537 Review. Romanian. No abstract available.